AIM
USDAIM ImmunoTech Inc. Common Stock
$1.600-0.400 (-20.000%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.000
High
$2.020
Low
$1.570
Volume
0.10M
Company Fundamentals
Market Cap
4.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.10M
Exchange
ASE
Currency
USD
52-Week Range
Low $1.57Current $1.600High $36
Related News
GlobeNewswire
AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
OCALA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical
View more
GlobeNewswire
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
OCALA, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that the European Patent Office has officially granted AIM's European Patent No. 4,096,675, titled
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.